Healthcare — Superinvestor Holdings
Pharmaceuticals, biotech, medical devices, healthcare providers, and managed care.
Last updated
$70.09B
Sector Total
36
Stocks Held
57
Managers Exposed
4.9%
% of Tracked Market
Across tracked superinvestor 13F filings, the Healthcare sector accounts for $70.09B in long equity positions (4.9% of combined market value), spread across 36 unique stocks held by 57 of 92 managers.
Top healthcare holdings
| Rank | Ticker | Company | Holders | Aggregate Value |
|---|---|---|---|---|
| 1 | CVS | CVS Health Corporation | 12 | $8.57B |
| 2 | UNH | Unitedhealth Group Inc | 20 | $7.88B |
| 3 | HUM | Humana, Inc. | 4 | $7.63B |
| 4 | ELV | Elevance Health, Inc. | 12 | $7.29B |
| 5 | CI | The Cigna Group | 8 | $4.27B |
| 6 | TMO | Thermo Fisher Scientific, Inc. | 18 | $3.89B |
| 7 | ZBH | Zimmer Biomet Holdings, Inc. | 9 | $3.33B |
| 8 | REGN | Regeneron Pharmaceuticals, Inc. | 4 | $3.24B |
| 9 | MDT | Medtronic, PLC | 10 | $3.19B |
| 10 | GILD | Gilead Sciences, Inc. | 5 | $3.05B |
| 11 | DHR | Danaher Corp. | 16 | $2.88B |
| 12 | HCA | HCA HEALTHCARE INC | 6 | $2.78B |
| 13 | MRK | Merck Inc | 14 | $1.78B |
| 14 | UHS | UNIVERSAL HLTH SVCS INC | 3 | $1.68B |
| 15 | LLY | Eli Lilly & Co. | 12 | $1.56B |
| 16 | SYK | Stryker Corp | 6 | $1.12B |
| 17 | BMY | Bristol-Myers Squibb | 10 | $1.04B |
| 18 | JNJ | Johnson & Johnson | 17 | $872.7M |
| 19 | CNC | CENTENE CORP DEL | 5 | $848.5M |
| 20 | ISRG | Intuitive Surgical | 6 | $788.3M |
| 21 | PFE | Pfizer, Inc. | 15 | $517.3M |
| 22 | DGX | Quest Diagnostics Inc. | 4 | $340.8M |
| 23 | BSX | Boston Scientific Corp. | 6 | $307.4M |
| 24 | VEEV | Veeva Systems Inc. Class A | 6 | $253.9M |
| 25 | ABT | Abbott Labs | 10 | $247.1M |
| 26 | LH | Labcorp Holdings, Inc. | 4 | $130.8M |
| 27 | BIIB | BIOGEN INC | 3 | $126.6M |
| 28 | MCK | MCKESSON CORP | 3 | $97.1M |
| 29 | AMGN | Amgen, Inc. | 7 | $93.0M |
| 30 | ABBV | Abbvie | 10 | $75.2M |
| 31 | TDOC | TELADOC HEALTH INC | 1 | $52.3M |
| 32 | BIIB | BIOGEN INC | 1 | $40.9M |
| 33 | EW | Edwards Lifesciences Corp | 4 | $40.4M |
| 34 | CAH | CARDINAL HEALTH INC | 5 | $36.7M |
| 35 | VRTX | Vertex Pharmaceuticals | 3 | $32.9M |
| 36 | TDOC | TELADOC HEALTH INC | 1 | $100K |